Market Research Logo

Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC,

Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021)(By Type: Imaging Tests, Endoscopy, Biopsy, Tumor Marker; By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography; By Region: North America, Latin America, APAC, Europe, MEA)

Executive Summary

Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.

Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.

Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.

Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.

Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 – 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research

North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.

According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)

Scope of the Report

The report provides Segmentation by Type

Imaging Tests
Endoscopy
Biopsy
Tumor Marker

The report provides Segmentation by Sub- Type

Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography

The report provides coverage by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis
4. Global Cancer Diagnostics Market: An Overview
4.1. Product Overview
4.1.1. Global Cancer Diagnostics Market, By Value 2011-2015
Table 1: Global Cancer Diagnostics Market, 2011-2015 (USD Billion)
Table 2: Global Population Above 65 Percentage of Total Population
Table 3: Major Cancer Among Women
Table 4: Major Cancer Among Men
Table 5: Estimated Cancer Incidences (approx.14 million) in 2012 with Regional Breakup
Table 6: Estimated Cancer Mortality (approx. 8 million) in 2012 with Regional Breakup
4.1.2. Global Cancer Diagnostics Market, By Value 2016-2021F
Table 7: Global Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Table 8: Global Population Above 65 (in Million)
Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market
4.1.1. By Value (Historic 2011-15)
Table 9: Global Cancer Diagnostic Imaging Test Market, By Value, 2011-2021F (in USD Billion)
4.1.2. By Value (Forecast 2016E-2021F)
4.1.3. By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
Table 10: Global Imaging Test Market, By Sub-Type, By Value, 2016E (In Percentage)
Table 11: Global Imaging Test Market, By Sub-Type, By Value, 2021F (In Percentage)
Table 12: Ultrasound Cancer Diagnostics Market, By Value, 2011-2021F (in USD Million)
Table 13: PET-CT Scan Market, By Value, 2011-2021F (in USD Million)
Table 14: Global Mammography Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
Table 15: MRI Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
4.2. Global Endoscopy Cancer Diagnostics Market
4.2.1. By Value (Historic 2011-15)
Table 16: Endoscopy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
4.2.2. By Value (Forecast 2016E-2021F)
4.3. Global Biopsy Market
4.3.1. By Value (Historic 2011-15)
Table 17: Biopsy Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
4.3.2. By Value (Forecast 2016E-2021F)
4.4. Global Tumour Marker Tests Market
4.4.1. By Value (Historic 2011-15)
Table 18: Tumour Marker Cancer Diagnostics Market, By Value, 2011-2021F (in USD Billion)
4.4.2. By Value (Forecast 2016E-2021F)
4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)
Table 19: Global Imaging Test Market, By Region, By Value, 2016E (In Percentage)
Table 20: Global Imaging Test Market, By Region, By Value2021F (In Percentage)
5. North America Cancer Diagnostics Market: An Overview
5.1. North America Cancer Diagnostics Market
5.1.1. By Value (Historic 2011-15)
Table 21: North America Cancer Diagnostics Market, 2011-2015 (USD Billion)
5.1.2. By Value (Forecast 2016E-2021F)
Table 22: North America Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Table 23: North America Population Above 65 as Percentage of Total Population
5.2. North America Cancer Diagnostics Country Overview – USA, Canada
6. APAC Cancer Diagnostics Market: An Overview
6.1. APAC Cancer Diagnostics Market
6.1.1. By Value (Historic 2011-15)
Table 24: APAC Cancer Diagnostics Market , 2011-2015 (USD Billion)
Table 25: South Asia Cancer Cases Within Major Countries, 2012
Table 26: Aging Population in South, East Asia and Pacific (in Percentage)
6.1.2. By Value (Forecast 2016E-2021F)
Table 27: APAC Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Table 28: APAC Population Above 65 as Percentage of Total Population
6.2. APAC Cancer Diagnostics Country Overview – India, China
7. Europe Cancer Diagnostics Market: An Overview
7.1. Europe Cancer Diagnostics Market
7.1.1. By Value (Historic 2011-15)
Table 29: Europe Cancer Diagnostics Market, 2011-2015 (USD Billion)
Table 30: Cancer Survival Rates in Europe in 2012 (in Percentage)
Table 31: Population Above 65 in European Union Region To Total Population (In Percentage)
7.1.2. By Value (Forecast 2016E-2021F)
Table 32: Europe Cancer Diagnostics Market Size, 2016E-2021F (USD Billion)
Table 33: Europe Population Above 65 as Percentage of Total Population
7.2. Europe Cancer Diagnostics Country Overview –Denmark, UK
8. Latin America Cancer Diagnostics Market: An Overview
8.1. Latin America Cancer Diagnostics Market
8.1.1. By Value (Historic 2011-15)
Table 34: Latin America Cancer Diagnostics Market, 2011-2015 (USD Million)
Table 35: Aging Population in Latin America (in Percentage)
8.1.2. By Value (Forecast 2016E-2021F)
Table 36: Latin America Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
Table 37: Latin America and Caribbean Population Above 65 as Percentage of Total Population
8.2. Latin America Cancer Diagnostics Country Overview – Chile, Brazil
9. MEA Cancer Diagnostics Market: An Overview
9.1. MEA Cancer Diagnostics Market
9.1.1. By Value (Historic 2011-15)
Table 38: MEA Cancer Diagnostics Market, 2011-2015 (USD Million)
Table 39: Estimated Incidences of Cancer in Africa Per 100,000 (Excluding non-melanoma skin cancer)
9.1.2. By Value (Forecast 2016E-2021F)
Table 40: MEA Cancer Diagnostics Market Size, 2016E-2021F (USD Million)
Table 41: MEA Population Above 65 as Percentage of Total Population
9.2. MEA Cancer Diagnostics Country Overview – UAE
10. Market Dynamics
10.1. Market Trends & Developments
10.2. Market Drivers
Table 42: Incidences of Cancer Globally
Table 43: Age Group Wise Annual Cases of Cancer between 2009-13 (in Percentage)
Table 44: Population Above 60 Percentage of the total Population Over the Years
10.3. Challenges
11. Policy Regulations
12. SWOT Analysis
13. Porter Five Force Model
14. Company Profiling
14.1. Abbott Laboratories
14.2. Becton Dickinson and Company
14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
14.4. General Electric Co (General Healthcare)
Table 45: Region Wise and Segment Wise Breakup for GE
14.5. Thermo Fisher Scientific
14.6. Agilent Technologies, Inc.
14.7. Illumina, Inc.
14.8. Hologic Inc.
14.9. C. R. Bard Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report